Control of intracellular pH during regulatory volume decrease in HL-60 cells.
Intracellular pH (pHi) homeostasis was investigated in human promyelocytic leukemic HL-60 cells as they undergo regulatory volume decrease (RVD) in hypotonic media to determine how well pHi is regulated and which transport systems are involved. Cells suspended in hypotonic (50-60% of isotonic) media undergo a small (< 0.2 pH units), but significant (P < 0.05), intracellular acidification within 5 min. However, after 30 min of RVD, pHi is not significantly different from the initial pHi in 20 mM HCO3- medium and is significantly higher in HCO3(-)-free medium. Experiments performed in media with or without 150 microM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and HCO3- demonstrate that the anion exchanger (AE) mediates a net Cl- influx, with compensating HCO3- efflux, during RVD. To determine which transport systems are involved in counteracting this tendency toward acidification, we measured transport rates and examined the effect of transport system inhibitors on pHi. We found that inhibition of Na+/H+ exchange (NHE) with 12.5 microM ethylisoproplamiloride (EIPA) causes pHi to fall significantly by the end of 30 min of RVD. As assessed by EIPA-sensitive 22Na+ uptake measurements, NHE, largely dormant under resting isotonic conditions, becomes significantly activated by the end of 30 min of RVD, despite recovery of pHi and cell volume to near-normal levels. Thus a shift in the normal pHi dependence and/or volume dependence of NHE activity must occur during RVD under hypotonic conditions. In contrast, H(+)-monocarboxylate cotransport appears to play only a supportive role in pH regulation during RVD, as indicated by lack of stimulation of [14C]lactate efflux during RVD.
Hallows
K R
KR
Department of Biophysics, University of Rochester Medical Center, New York 14642.
Restrepo
D
D
Knauf
P A
PA
D000838:Anions / Q000493:pharmacokinetics; D002352:Carrier Proteins / Q000378:metabolism; D002712:Chlorides / Q000493:pharmacokinetics; D003373:Coumaric Acids / Q000494:pharmacology; D003470:Culture Media; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007425:Intracellular Membranes / Q000378:metabolism*; D007474:Ion Exchange; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D015473:Leukemia, Promyelocytic, Acute / Q000378:metabolism* / Q000473:pathology; D027501:Monocarboxylic Acid Transporters; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000838:Anions; D002352:Carrier Proteins; D002712:Chlorides; D003373:Coumaric Acids; D003470:Culture Media; D007773:Lactates; D027501:Monocarboxylic Acid Transporters; D017923:Sodium-Hydrogen Exchangers; C007175:alpha-cyano-4-hydroxycinnamate; D019344:Lactic Acid